New genetic testing has been developed at the University of Oxford to detect early signs of a potentially fatal condition that can also develop into full blown leukaemia in children with Down's syndrome.
Jun 20, 2018
0
100
For 40 years, researchers have believed there is an increased risk of cancer associated with styrene. Now, a working group under the auspices of the WHO and appointed by the International Agency for Research on Cancer (IARC), ...
Jun 1, 2018
0
30
A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance, a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) ...
May 30, 2018
0
3
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, following more than a century of controversy about its origins.
May 21, 2018
0
3329
Scientists have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome. Researchers at the Wellcome Sanger Institute and the University of Cambridge found that this Y-chromosome gene ...
May 7, 2018
0
154
The key genetic events responsible for initiating the early stages of a type of childhood leukaemia have been identified by scientists at The Institute of Cancer Research, London. Insights into the 'founder' genetic mutation ...
Apr 5, 2018
0
22
Acute myeloid leukaemia is the most common type of acute cancer of the blood and bone marrow in adults. AML progresses quickly and only 26 percent of the patients survive longer than five years as resistance against established ...
Feb 23, 2018
0
6
Adults with acute lymphoblastic leukaemia living in deprived areas of England have poorer survival rates, a new study has found.
Feb 1, 2018
0
1
When people think of leukaemia, they usually think of blood cancers that affect children. These mostly come under the category of acute lymphoblastic leukaemia – or ALL – and are different to the group of blood cancers ...
Jan 16, 2018
0
9
Patients with an aggressive form of leukaemia, currently ineligible for any type of targeted therapy, may in fact benefit from some of these new drugs, according to new research by Queen Mary University of London.
Jan 9, 2018
0
1
